A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells

12.1K views

⸱

DOI:

10.3791/52298

⸱

January 28th, 2015

 ,  ,  ,  ,  , 

In This Article

Summary

A method was developed to directly derive human neural stem cells from hematopoietic progenitor cells enriched from peripheral blood cells.

Abstract

Human disease specific neuronal cultures are essential for generating in vitro models for human neurological diseases. However, the lack of access to primary human adult neural cultures raises unique challenges. Recent developments in induced pluripotent stem cells (iPSC) provides an alternative approach to derive neural cultures from skin fibroblasts through patient specific iPSC, but this process is labor intensive, requires special expertise and large amounts of resources, and can take several months. This prevents the wide application of this technology to the study of neurological diseases. To overcome some of these issues, we have developed a method to derive neural stem cells directly from human adult peripheral blood, bypassing the iPSC derivation process. Hematopoietic progenitor cells enriched from human adult peripheral blood were cultured in vitro and transfected with Sendai virus vectors containing transcriptional factors Sox2, Oct3/4, Klf4, and c-Myc. The transfection results in morphological changes in the cells which are further selected by using human neural progenitor medium containing basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF). The resulting cells are characterized by the expression for neural stem cell markers, such as nestin and SOX2. These neural stem cells could be further differentiated to neurons, astroglia and oligodendrocytes in specified differentiation media. Using easily accessible human peripheral blood samples, this method could be used to derive neural stem cells for further differentiation to neural cells for in vitro modeling of neurological disorders and may advance studies related to the pathogenesis and treatment of those diseases.

Introduction

In vitro neuronal cultures have been used as a fundamental tool for studies of neurological diseases. Primary animal (mostly rodent) neural cultures1,2 and human neural cell lines derived from gliomas or other tumors are the most commonly used in such studies. However, it has been recognized that there are significant differences between rodent and human cells. Many findings based on rodents cannot be translated to humans. Furthermore, with the rapid developments in analyzing mass genomic information and the relatively easy gene editing and whole genome sequencing, the trend is more and more geared to discovering disease prone genes and ....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Enrichment of Hematopoietic Progenitor Cells from Adult Whole Blood

NOTE: Hematopoietic progenitor cells or CD34+ cells can be purified from peripheral blood mononuclear cells (PBMCs) derived from a variety of sources including cord blood, leukapheresis material and whole blood using density gradient centrifugation based methods. The method listed here uses whole blood as an example.

  1. Isolation of PBMCs from Whole Blood:
    1. Add 4.5 ml of lymphocyte separation medium to the SepMate tube by pipetting it through the central hole of the insert.
    2. Dilute the blood sample with an equal volume of sterile DPBS contai....

Access restricted. Please log in or start a trial to view this content.

Results

The quality of CD34 cells is critical for the success of neural stem cell transduction. High quality CD34 cells proliferate during the first couple of days of culture and appear as non adherent, homogenously round cells, floating just above the bottom of culture vessels (Figure 1A). The successful infection results in cell aggregates, which expands over time (Figure 1B), while non specific cell aggregates may occur during cell culture, that expand and the associations are loose. Adherent.......

Access restricted. Please log in or start a trial to view this content.

Discussion

A detailed protocol to directly generate neural stem cells from peripheral hematopoietic progenitor cells is provided.

Compared to fibroblast cells, human peripheral blood is more accessible. Using the presented protocol, more than 1 x 105 hematopoietic progenitor cells, or CD34 positive cells, can be enriched from 10 ml of whole blood. Although contamination with platelets is usually not preventable, it can be easily reduced by lower speed centrifugation and it does not interfere w.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The study is funded by NIH intramural funds.

Acknowledgements

The authors have no conflicts of interest to disclose.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Lymphocyte separation mediumLonza17-829E1x
SepMateStemcell Technologies1541515 ml
Human serumInvitrogen34005-100
AntibioticsGibco15240-0621%
CD34 MultiSort KitMiltenyi Biotec130-056-701
EDTACellgro46-034-Cl2 mM
MACS LS columnMiltenyi Biotec130-042-401
StemSpan SFEM mediumStemcell Technologies96501x
IMDMQuality Biologicals112-035-1011x
TPOPeprotech300-18100 ng/ml
Flt-3Peprotech300-19100 ng/ml
SCFPeprotech300-07100 ng/ml
IL-6Peprotech200-0620 ng/ml
IL-7Peprotech200-0720 ng/ml
IPS Sendai Reprogramming KitLife TechnologiesA1378001
Cell scraperSarstedt83.183
DMSOSigmaD2650
CryoTube vialsThermo368632
Mr. Frosty containerThermo5100-0001
DMEM/F12Life Technologies12400-0241x
N2 supplementLife Technologies17502-0481x
Bovine serum albuminSigmaA29340.1% (w/v)
bFGFPeprotech100-18B20 ng/ml
EGFPeprotechAF-100-15
B27 supplementLife Technologies17504-0441x
NSC serum free mediumLife TechnologiesA10509011x
Poly-D-lysine/laminin coated cover slipsBD Bioscences354087
cAMPSigmaA9501300 ng/ml
Vitamin CSigmaA02780.2 mM
BDNFPeprotech450-0210 ng/ml
GDNFPeprotech450-1010 ng/ml
Poly-L-ornithineSigmaP49571x
PDGF-AAPeprotech100-13A10 ng/ml
NT-3Peprotech450-032 ng/ml
ShhPeprotech1314-SH/CF2 ng/ml
T3SigmaT63973 nM
PFASigmaP61484%
PBSQuality Biological119-069-1011x
Goat serumSigmaG90234%
TritonX-100SigmaT9284
Mouse monoclonal anti-NestinMilliporeAB59221:1,000 dilution
Anti-SOX2 antibodyApplied StemcellASA0120Ready to use
Mouse anti-βIII-tubulin antibodyPromegaG712A1:1,000 dilution
Rabbit anti-GFAP antibodySigmaG45461:100 dilution
Anti-O4 antibodyR&D SystemsMAB1326IgM; 1 ng/ml
Alexa Fluor 594 goat anti-rabbit antibodyLife techniologiesA110121:400 dilution
Alexa Fluor 488 goat anti-mouse antibodyLife techniologiesA110011:400 dilution
Alexa Fluor 488 goat anti-mouse IgM antibodyLife techniologiesA210421:250 dilution
DAPISigmaD95421 μg/ml

References

  1. Azari, H., et al. Purification of immature neuronal cells from neural stem cell progeny. PLoS ONE. 6, e20941(2011).
  2. Azari, H., Sharififar, S., Fortin, J. M., Reynolds, B. A. The neurob....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Sendai Virus TransfectionPeripheral Blood CD34Neural Progenitor MediumImmunofluorescence MicroscopyNestin SOX2 ExpressionNeuronal DifferentiationAstrocyte Oligodendrocyte GenerationDirect Induction Method